未知生产厂商
Galiximab is a chimeric monoclonal antibody which is used as an immunosuppressive drug.
Galiximab is a chimeric monoclonal antibody which is used as an immunosuppressive drug.
Galiximab, an IgG(1) anti-CD80 antibody, binds to CD80, a costimulatory molecule involved in T-cell activation. Reduction in lesional, activated T cells induces improvement in psoriatic plaques.
Investigated for use/treatment in lymphoma (non-hodgkin's), psoriasis and psoriatic disorders, bone metastases, multiple myeloma, prostate cancer, and rheumatoid arthritis.
